Massimo Zollo

ORCID: 0000-0002-0970-7243
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mechanisms of cancer metastasis
  • Cancer Mechanisms and Therapy
  • SARS-CoV-2 and COVID-19 Research
  • Ferrocene Chemistry and Applications
  • Glioma Diagnosis and Treatment
  • MicroRNA in disease regulation
  • COVID-19 Clinical Research Studies
  • Hedgehog Signaling Pathway Studies
  • Signaling Pathways in Disease
  • Epigenetics and DNA Methylation
  • Circular RNAs in diseases
  • Cancer-related molecular mechanisms research
  • Chromatin Remodeling and Cancer
  • Peptidase Inhibition and Analysis
  • RNA modifications and cancer
  • SARS-CoV-2 detection and testing
  • Genetics and Neurodevelopmental Disorders
  • Genomics and Chromatin Dynamics
  • Histone Deacetylase Inhibitors Research
  • Synthesis and biological activity
  • Pancreatic function and diabetes
  • Neuroblastoma Research and Treatments
  • RNA Research and Splicing
  • Cancer Genomics and Diagnostics
  • Trace Elements in Health

Federico II University Hospital
2009-2025

University of Naples Federico II
2015-2024

Ceinge Biotecnologie Avanzate (Italy)
2014-2024

European School of Molecular Medicine
2016-2024

Ospedale Pediatrico Giovanni XXIII
2024

University of Milan
2017-2020

Princess Margaret Cancer Centre
2016

Hospital for Sick Children
2016

SickKids Foundation
2016

British Columbia Children's Hospital
2016

Florence M.G. Cavalli Marc Remke Ladislav Rampášek John Peacock David Shih and 90 more Betty Luu Livia Garzia Jonathon Torchia Carolina Nör A. Sorana Morrissy Sameer Agnihotri Yuan Thompson Claudia M. Kuzan-Fischer Hamza Farooq Keren Isaev Craig Daniels Byung-Kyu Cho Seung-Ki Kim Kyu‐Chang Wang Ji Yeoun Lee Wiesława Grajkowska Marta Perek‐Polnik Alexandre Vasiljevic Cécile Faure‐Conter Anne Jouvet Caterina Giannini Amulya A. Nageswara Rao Kay Ka Wai Li Ho‐Keung Ng Charles G. Eberhart Ian F. Pollack Ronald L. Hamilton G. Yancey Gillespie James M. Olson Sarah Leary William A. Weiss Bolesław Lach Lola B. Chambless Reid C. Thompson Michael K. Cooper Rajeev Vibhakar Péter Hauser Marie‐Lise C. van Veelen Johan M. Kros Pim J. French Young Seob Shin Toshihiro Kumabe Enrique López‐Aguilar Karel Zitterbart Jaroslav Štěrba Gaetano Finocchiaro Maura Massimino Erwin G. Van Meir Satoru Osuka Tomoko Shofuda Álmos Klekner Massimo Zollo Jeffrey R. Leonard Joshua B. Rubin Nada Jabado Steffen Albrecht Jaume Mora Timothy Van Meter Shin Jung Andrew S. Moore Andrew R. Hallahan Jennifer A. Chan Daniela Pretti da Cunha Tirapelli Carlos Gilberto Carlotti Maryam Fouladi José Pimentel Cláudia C. Faria Ali G. Saad Luca Massimi Linda M. Liau Helen Wheeler Hideo Nakamura Samer K. Elbabaa Mario Pérezpeña-Díazconti Fernando Chico Ponce de León Shenandoah Robinson Michal Zápotocký Álvaro Lassaletta Annie Huang Cynthia Hawkins Uri Tabori Éric Bouffet Ute Bartels Peter B. Dirks James T. Rutka Gary D. Bader Jüri Reimand Anna Goldenberg Vijay Ramaswamy Michael D. Taylor

10.1016/j.ccell.2017.05.005 article EN publisher-specific-oa Cancer Cell 2017-06-01

Medulloblastoma comprises four distinct molecular subgroups: WNT, SHH, Group 3, and 4. Current medulloblastoma protocols stratify patients based on clinical features: patient age, metastatic stage, extent of resection, histologic variant. Stark prognostic genetic differences among the subgroups suggest that subgroup-specific biomarkers could improve prognostication.Molecular were identified from a discovery set 673 medulloblastomas 43 cities around world. Combined risk stratification models...

10.1200/jco.2013.50.9539 article EN Journal of Clinical Oncology 2014-02-04
Vijay Ramaswamy Thomas Hielscher Stephen C. Mack Álvaro Lassaletta Tong Lin and 95 more Kristian W. Pajtler David Jones Betty Luu Florence M.G. Cavalli Kenneth Aldape Marc Remke Martin Mynarek Stefan Rutkowski Sridharan Gururangan Roger E. McLendon Eric Lipp Christopher Dunham Juliette Hukin David D. Eisenstat Dorcas Fulton Frank K.H. van Landeghem Mariarita Santi Marie‐Lise C. van Veelen Erwin G. Van Meir Satoru Osuka Xing Fan Karin M. Muraszko Daniela Pretti da Cunha Tirapelli Sueli Mieko Oba‐Shinjo Suely Kazue Nagahashi Marie Carlos Gilberto Carlotti Ji Yeoun Lee Amulya A. Nageswara Rao Caterina Giannini Cláudia C. Faria Sofia Nunes Jaume Mora Ronald L. Hamilton Péter Hauser Nada Jabado Kevin Petrecca Shin Jung Luca Massimi Massimo Zollo Giuseppe Cinalli László Bognár Álmos Klekner Tibor Hortobágyi Sarah Leary Ralph Ermoian James M. Olson Jeffrey R. Leonard Corrine Gardner Wiesława Grajkowska Lola B. Chambless Jason Cain Charles G. Eberhart Sama Ahsan Maura Massimino Felice Giangaspero Francesca Romana Buttarelli Roger J. Packer Lyndsey Emery William H. Yong Horacio Soto Linda M. Liau Richard G. Everson Andrew J. Grossbach Tarek Shalaby Michael Grotzer Matthias A. Karajannis David Zagzag Helen Wheeler Katja von Hoff Marta M. Alonso T. Tuñón Ulrich Schüller Karel Zitterbart Jaroslav Štěrba Jennifer A. Chan Miguel A. Guzmán Samer K. Elbabaa Howard Colman Girish Dhall Paul G. Fisher Maryam Fouladi Amar Gajjar Stewart Goldman Eugene Hwang Marcel Kool Harshad Ladha Elizabeth Vera‐Bolanos Khalida Wani Frank S. Lieberman Tom Mikkelsen Antonio Omuro Ian F. Pollack Michael D. Prados H. Ian Robins Riccardo Soffietti

Posterior fossa ependymoma comprises two distinct molecular variants termed EPN_PFA and EPN_PFB that have a biology natural history. The therapeutic value of cytoreductive surgery radiation therapy for posterior after accounting subgroup is not known.Four independent nonoverlapping retrospective cohorts ependymomas (n = 820) were profiled using genome-wide methylation arrays. Risk stratification models designed based on known clinical newly described biomarkers identified by multivariable...

10.1200/jco.2015.65.7825 article EN Journal of Clinical Oncology 2016-06-07
Liam D. Hendrikse Parthiv Haldipur Olivier Saulnier Jake Millman Alexandria H. Sjoboen and 95 more Anders W. Erickson Winnie Ong Victor Gordon Ludivine Coudière-Morrison Audrey Mercier Mohammad Shokouhian Raúl A. Suárez Michelle Ly Stephanie Borlase David S. Scott Maria C. Vladoiu Hamza Farooq Olga Sirbu Takuma Nakashima Shohei Nambu Yusuke Funakoshi Alec Bahcheli J. Javier Díaz-Mejía Joseph Golser Kathleen Bach Tram Phuong-Bao Patryk Skowron Evan Y. Wang Sachin Kumar Polina Balin Abhirami Visvanathan John J. Y. Lee Ramy Ayoub Xin Chen Xiaodi Chen Karen Mungall Betty Luu Pierre Bérubé Yu C. Wang Stefan M. Pfister Seung-Ki Kim Olivier Delattre Franck Bourdeaut François Doz Julien Masliah‐Planchon Wiesława Grajkowska James Loukides Peter B. Dirks Michelle Fèvre‐Montange Anne Jouvet Pim J. French Johan M. Kros Karel Zitterbart Swneke D. Bailey Charles G. Eberhart Amulya A. Nageswara Rao Caterina Giannini James M. Olson Miklós Garami Péter Hauser Joanna J. Phillips Stephanie Young Carmen de Torres Jaume Mora Kay K. W. Li Ho‐Keung Ng Wai Sang Poon Ian F. Pollack Enrique López‐Aguilar G. Yancey Gillespie Timothy Van Meter Tomoko Shofuda Rajeev Vibhakar Reid C. Thompson Michael K. Cooper Joshua B. Rubin Toshihiro Kumabe Shin Jung Bolesław Lach Achille Iolascon Veronica Ferrucci Pasqualino de Antonellis Massimo Zollo Giuseppe Cinalli Shenandoah Robinson Duncan Stearns Erwin G. Van Meir Paola Porrati Gaetano Finocchiaro Maura Massimino Carlos Gilberto Carlotti Cláudia C. Faria Martine F. Roussel Frederick A. Boop Jennifer A. Chan Kimberly A. Aldinger Ferechté Razavi Evelina Silvestri Roger E. McLendon Eric M. Thompson

10.1038/s41586-022-05215-w article EN Nature 2022-09-21

Background Through negative regulation of gene expression, microRNAs (miRNAs) can function in cancers as oncosuppressors, and they show altered expression various tumor types. Here we have investigated medulloblastoma tumors (MBs), which arise from an early impairment developmental processes the cerebellum, where Notch signaling is involved many cell-fate-determining stages. MBs occur bimodally, with peak incidence seen between 3–4 years 8–9 age, although it also adults. regulates a subset...

10.1371/journal.pone.0004998 article EN cc-by PLoS ONE 2009-03-23

Background Through negative regulation of gene expression, microRNAs (miRNAs) can function as oncosuppressors in cancers, and themselves show altered expression various tumor types. Here, we have investigated medulloblastoma tumors (MBs), which arise from an early impairment developmental processes the cerebellum, where Notch signaling is involved many cell-fate-determining stages. regulates a subset MB cells that stem-cell-like properties promote growth. On basis this evidence, hypothesized...

10.1371/journal.pone.0024584 article EN cc-by PLoS ONE 2011-09-12

Telomerase reverse transcriptase (TERT) promoter mutations were recently shown to drive telomerase activity in various cancer types, including medulloblastoma. However, the clinical and biological implications of TERT medulloblastoma have not been described. Hence, we sought describe these their impact a subgroup-specific manner. We analyzed by direct sequencing genotyping 466 medulloblastomas. The mutational distributions determined according subgroup affiliation, demographics, clinical,...

10.1007/s00401-013-1198-2 article EN cc-by Acta Neuropathologica 2013-10-30

The established risk factors of coronavirus disease 2019 (COVID-19) are advanced age, male sex, and comorbidities, but they do not fully explain the wide spectrum manifestations. Genetic implicated in host antiviral response provide for novel insights into its pathogenesis.We performed an in-depth genetic analysis chromosome 21 exploiting genome-wide association study data, including 6,406 individuals hospitalized COVID-19 902,088 controls with European ancestry from Host Genetics...

10.1016/j.isci.2021.102322 article EN cc-by-nc-nd iScience 2021-03-19

The DHH superfamily human protein h-prune, a binding partner of the metastasis suppressor nm23-H1, is frequently overexpressed in metastatic cancers. From an evolutionary perspective, h-prune very close to eukaryotic exopolyphosphatases. Here, we show for first time that efficiently hydrolyzes short-chain polyphosphates (kcat 3−40 s−1), including inorganic tripoly- and tetrapolyphosphates nucleoside 5′-tetraphosphates. Long-chain (≥25 phosphate residues) are converted more slowly, whereas...

10.1021/bi8010847 article EN Biochemistry 2008-08-14

h-prune, which has been suggested to be involved in cell migration, was identified as a glycogen synthase kinase 3 (GSK-3)-binding protein. Treatment of cultured cells with GSK-3 inhibitors or small interfering RNA (siRNA) for and h-prune inhibited their motility. The activity required the interaction h-prune. localized focal adhesions, siRNA delayed disassembly paxillin. tyrosine phosphorylation adhesion (FAK) activation Rac were suppressed knocked-down cells. paxillin FAK Rac. Furthermore,...

10.1128/mcb.26.3.898-911.2006 article EN Molecular and Cellular Biology 2006-01-20

PRUNE is a member of the DHH (Asp-His-His) phosphoesterase protein superfamily molecules important for cell motility, and implicated in cancer progression. Here we investigated multiple families from Oman, India, Iran Italy with individuals affected by new autosomal recessive neurodevelopmental degenerative disorder which cardinal features include primary microcephaly profound global developmental delay. Our genetic studies identified biallelic mutations PRUNE1 as responsible. functional...

10.1093/brain/awx014 article EN cc-by Brain 2017-02-15
Stéphanie Efthymiou Vincenzo Salpietro Nancy T. Malintan Mallory Poncelet Yamna Kriouile and 90 more Sara Fortuna Rita De Zorzi Katelyn Payne Lindsay B. Henderson Andrea Cortese Sateesh Maddirevula Nadia Alhashmi Sarah Wiethoff Mina Ryten Juan A. Botía Vincenzo Provitera Markus Schuelke Jana Vandrovcová Stanislav Groppa Blagovesta Marinova Karashova Wolfgang Nachbauer Sylvia Boesch Larissa Arning Dagmar Timmann Bru Cormand Belén Pérez‐Dueñas Jatinder S. Goraya Tipu Sultan Jun Mine Daniela Avdjieva Hadil Kathom Radka Tincheva Selina Banu Mercedes Pineda-Marfa Pierangelo Veggiotti Michel D. Ferrari Arn M. J. M. van den Maagdenberg Alberto Verrotti Gian Luigi Marseglia Salvatore Savasta Mayte García-Silva Alfons Macaya Ruiz Barbara Garavaglia Eugenia Borgione Simona Portaro Benigno Monteagudo Sanchez Richard G. Boles Savvas Papacostas Michail Vikelis James E. Rothman Dimitri M. Kullmann Eleni Zamba Papanicolaou Efthimios Dardiotis Shazia Maqbool Shahnaz Ibrahim Salman Kirmani Nuzhat Rana Osama Atawneh Shen‐Yang Lim Mohd. Farooq Shaikh Georgios Koutsis Marianthi Breza Salvatore Mangano Carmela Scuderi Eugenia Borgione Giovanna Morello Tanya Stojkovic Massimo Zollo Gali Heimer Yves Dauvilliers Carlo Minetti Issam Al-Khawaja Fuad Al-Mutairi Sherifa A. Hamed Menelaos Pipis Conceição Bettencourt Simon Rinaldi Laurence E. Walsh Erin Torti Valeria Iodice Maryam Najafi Ehsan Ghayoor Karimiani Reza Maroofian Karine Siquier-Pernet Nathalie Boddaert Pascale de Lonlay Vincent Cantagrel M. Aguennouz M. El Khorassani Miriam Schmidts Fowzan S. Alkuraya Simon Edvardson Maria Nolano Jérôme Devaux Henry Houlden

See Karakaya and Wirth (doi:10.1093/brain/awz273) for a scientific commentary on this article. Neurofascin (NFASC) isoforms are immunoglobulin cell adhesion molecules involved in node of Ranvier assembly. Efthymiou et al. identify biallelic NFASC variants ten unrelated patients with neurodevelopmental disorder characterized by variable degrees central peripheral involvement. Abnormal expression Nfasc155 is accompanied severe loss myelinated fibres.

10.1093/brain/awz248 article EN cc-by Brain 2019-07-26
Coming Soon ...